Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
268.89%
Change (1 year)
Categories
Corbus Pharmaceuticals (CRBP) - Cash on Hand
Cash on Hand as of December 2023 : $20.9 M
According to Corbus Pharmaceuticals
's latest financial reports the company has $20.9 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Corbus Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $20.9 M | -64.68% |
| 2022-12-31 | $59.19 M | -39.38% |
| 2021-12-31 | $97.64 M | 14.3% |
| 2020-12-31 | $85.43 M | 169.09% |
| 2019-12-31 | $31.74 M | -23.95% |
| 2018-12-31 | $41.74 M | -33.24% |
| 2017-12-31 | $62.53 M | 317.13% |
| 2016-12-31 | $14.99 M | 21.51% |
| 2015-12-31 | $12.33 M | 97.02% |
| 2014-12-31 | $6.26 M | 1966.68% |
| 2013-12-31 | $0.3 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $0.96 B | 4,506.22% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.38 B | 1,757.19% | 🇺🇸 USA |
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | $4.88 M | -76.65% | 🇺🇸 USA |